Search Results
Mar 24, 2026, 08:30 ET HKeyBio Launches HKEY-NHP-onChip™ 1.1: World's First NHP In Vitro Model for Autoimmune and Allergic Diseases
simulating intestinal permeability, lung epithelial-immune interactions, and skin microenvironmentNHP co-culture systems integrating immune cells (T cells, B cells, mast cells, myeloid cells) with full tissue reconstruction of skin, lung, and intestinal environmentsDimension 2: Human
More news about: HKeyBio
Mar 24, 2026, 08:02 ET Заказ двух лабораторных тестов -- СОЭ и СРБ -- может сэкономить больницам миллионы в год. Новое исследование ставит под вопрос взаимозаменяемость этих тестов
просто является разумным решением.Об исследованииЦитирование: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. «Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests.» ClinicoEconomics and Outcomes
More news about: Alcor Scientific
Mar 24, 2026, 08:01 ET Aethlon Medical, Inc. Advances to Final Cohort in Oncology Clinical Trial Following Positive DSMB Review
complications; the possibility of novel treatment strategies; how the Hemopurifier may reduce tumor-derived extracellular vesicles and enhance T cell activity against tumors; the efficacy of continued clinical trials; development under IDE for indications; and/or the number of patients enrolled
More news about: Aethlon Medical, Inc.
Mar 24, 2026, 08:00 ET Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to advance Continuity's NICHE® cell-therapy platform toward a planned first-in-human clinical study for people living with T1D.
More news about: Continuity Biosciences LLC
Mar 24, 2026, 08:00 ET Continuity Biosciences and Breakthrough T1D Collaborate to Advance NICHE® Cell-Therapy Platform Toward First-in-Human Study
Biosciences and Breakthrough T1D, the leading global type 1 diabetes (T1D) advocacy organization, today announced a strategic collaboration to advance Continuity's NICHE® cell-therapy platform toward a planned first-in-human clinical study for people living with T1D.
More news about: Continuity Biosciences LLC
Mar 24, 2026, 08:00 ET Optellum AI Shown to be Highly Cost-Effective in First US Lifetime Payer Study of Lung Nodule Risk Stratification
with an incremental cost of about $114 per patient using reimbursement of $650 based on Medicare hospital outpatient payments for CPT codes 0721T and 0722T. [1] This yields an incremental cost-effectiveness ratio (ICER) of $4,485 per life-year gained (LYG), well below commonly used willingness-to-pay
More news about: Optellum
Mar 24, 2026, 08:00 ET Citius Oncology to Participate in USCLC Annual Workshop 2026, Highlighting LYMPHIR™ in Discussions with Leading Cutaneous Lymphoma Experts
immunosuppressive regulatory T lymphocytes (Tregs) and antitumor activity through a direct cytocidal action on IL-2R-expressing tumors.In 2021, denileukin diftitox received regulatory approval in Japan for the treatment of relapsed or refractory CTCL and peripheral T-cell lymphoma (PTCL). Subsequently,
More news about: Citius Oncology, Inc.
Mar 24, 2026, 07:55 ET Yêu cầu cả xét nghiệm ESR và CRP có thể giúp các bệnh viện tiết kiệm hàng triệu đô la mỗi năm -- Nghiên cứu mới thách thức quan niệm cho rằng hai xét nghiệm này có thể thay thế cho nhau
thiết là điều hoàn toàn hợp lý.Giới thiệu về Nghiên cứuTrích dẫn: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests." ("Đánh giá kinh tế về các chiến
More news about: Alcor Scientific
Mar 24, 2026, 07:50 ET Partillion Bioscience Advances a New Era of Cell-Cell Interaction Mapping at the 2026 Cell-Cell Symposium
cell types for downstream analysis, noting, "We have developed approaches to pair and synchronize the contact of cells — for example, tumor cells and T cells — put them into single-cell transcriptomics, and derive composite transcriptomes."Partillion's participation underscored how the company's
More news about: Partillion Bioscience
Mar 24, 2026, 07:46 ET Solicitar análisis de laboratorio de VSG y PCR podría ahorrar a los hospitales millones de dólares al año
lógico.Acerca del estudioCita: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Evaluación económica de estrategias de pruebas combinadas mediante la velocidad de sedimentación globular y la proteína C reactiva". ClinicoEconomics
More news about: Alcor Scientific
Mar 24, 2026, 07:44 ET WuXi Biologics Reports Record 2025 Annual Results
2025, generating record-high upfront and total payments, and securing potential milestone and royalties over US$4 billion.CD3 T-cell engager (TCE) partnerships continued to expand during the year, reflecting growing industry adoption of the Group's leading CD3 platform. The platform
More news about: WuXi Biologics
Mar 24, 2026, 07:35 ET ESR 검사와 CRP 검사를 모두 처방함으로써 병원이 연간 수백만 달러를 절감할 수 있어… 새 연구, 두 검사가 서로 대체 가능하다는 개념에 도전
합리적인 선택이라 할 수 있다.연구 소개인용: 얀오프 B(Yarnoff B), 모리스 W(Morris W), 지바리피란 H(Zivaripiran H), 맥커천 M(McCutcheon M), 코시 T(Koshy T). "적혈구 침강 속도 및 C-반응성 단백질 검사를 사용한 결합 검사 전략의 경제적 평가(Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive
More news about: Alcor Scientific
Mar 24, 2026, 07:30 ET Upstage AI Named to Fast Company's Annual List of the World's Most Innovative Companies of 2026
fastcompany.com.Media ContactBlaire Swayze, Director of InsurTech Comms & PRT Palmer [email protected]
More news about: Upstage AI
Mar 24, 2026, 07:30 ET Invesco and Superstate Advance Institutional Tokenization Through USTB Partnership
Invesco, a $2.2T global asset manager, to become the investment manager of Superstate's flagship tokenized short-duration U.S. treasuries fund, USTBATLANTA and NEW YORK, March 24, 2026 /PRNewswire/ -- Invesco
More news about: Invesco Ltd.
Mar 24, 2026, 07:30 ET Origin Agritech Names Global Crop Biotechnology Expert Dr. Jian Zhang to Board of Directors; Welcomes Return of Dr. Z. James Chen as Chief Financial Officer
Inc. Earlier in his career, he was an Investment Manager at the Abu Dhabi Investment Authority (ADIA), an senior analyst at Morgan Joseph and BB&T Capital Markets, a Product Manager at Celanese, and a License Product Technology Manager at Univation Technologies — a joint venture between ExxonMobil
More news about: Origin Agritech
Mar 24, 2026, 07:19 ET PrimeXBT receives 'Best Trading Conditions' and 'Best Forex & CFD Broker' awards for Asia
can afford the high risk of losing their money. The Company does not accept clients from the Restricted Jurisdictions as indicated on its website / T&Cs. Some products and services, including MT5, may not be available in their jurisdiction. The applicable legal entity and its respective products and
More news about: PrimeXBT
Mar 24, 2026, 07:13 ET Die Bestellung von sowohl ESR- als auch CRP-Labortests könnte Krankenhäusern Millionen pro Jahr sparen - neue Studie stellt die Vorstellung in Frage, dass die Tests austauschbar sind
Folgetests zu vermeiden, ist jedoch sinnvoll.Über die StudieZitat: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. „Ökonomische Bewertung kombinierter Teststrategien unter Verwendung von Erythrozyten-Sedimentationsraten- und C-reaktiven Proteintests". ClinicoEconomics
More news about: Alcor Scientific
Mar 24, 2026, 07:06 ET La commande des deux tests de laboratoire ESR et CRP pourrait permettre aux hôpitaux d'économiser des millions par an - Une nouvelle étude remet en question l'idée que les tests sont interchangeables.
entièrement automatisés et peu coûteux - contribue à réduire les erreurs de diagnostic, pourquoi la pression exercée pour réduire l'analyse de l'ESR persiste-t-elle ? L'impact réel de l'analyse simultanée de l'ESR et de la CRP dépend de l'institution, de la maladie, de la population de patients, de la prévalence
More news about: Alcor Scientific
Mar 24, 2026, 07:00 ET Sweet Victory Gum Helps Type 1 Diabetics Halve Sweets Snacking in Pilot Clinical Trial
24, 2026 /PRNewswire/ -- Results of a new clinical pilot study reveal that chewing Sweet Victory gum could help patients with type 1 diabetes (T1DM) reduce sweet snacking by more than half. The functional chewing gum, formulated with powdered leaves of the Gymnema sylvestre plant was designed
More news about: Sweet Victory
Mar 24, 2026, 07:00 ET 27 Years, 260,000 Appliances: Whirlpool Celebrates Habitat for Humanity's 50th Anniversary and Improving Lives and Communities Together
Project T, a revitalization initiative targeting working families in Benton Harbor, Michigan.That same belief in supporting American families also drives
More news about: Whirlpool Corporation
Mar 24, 2026, 06:59 ET Microirrigation Systems Market worth $21.56 billion by 2030 - Exclusive Report by MarketsandMarkets™
Company (US), Netafim (Israel), Nelson Irrigation (US), Rain Bird Corporation (US), Finolex Plasson (India), Mahindra EPC Irrigation Limited (India), T-L Irrigation (US), Hunter Industries (US), Rivulis (Israel), Chinadrip irrigation Equipment co., Ltd. (China), Elgo Irrigation Ltd. (Israel), Antelco
More news about: MarketsandMarkets
Mar 24, 2026, 06:51 ET Solicitar testes laboratoriais de VHS e PCR poderia economizar milhões de hospitais por ano -- Novo estudo desafia a noção de que os testes são intercambiáveis
acompanhamento desnecessários faz todo o sentido.Sobre o estudoCitação: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests." Pesquisa de resultados e economia
More news about: Alcor Scientific
Mar 24, 2026, 06:42 ET Pedir pruebas de laboratorio de VSG y PCR podría ahorrar a los hospitales millones por año: un nuevo estudio desafía la noción de que las pruebas son intercambiables
seguimiento innecesarias tiene sentido.Acerca del estudioCita: Yarnoff B, Morris W, Zivaripiran H, McCutcheon M, Koshy T. "Economic Evaluation of Combined Testing Strategies Using Erythrocyte Sedimentation Rate and C-Reactive Protein Tests". ClinicoEconomics and Outcomes
More news about: Alcor Scientific
Mar 24, 2026, 06:00 ET Feedzai Unveils RiskFM AI Foundation Model for Financial Crime Prevention
actively adapt to evade detection in real-time."Feedzai is uniquely positioned to explore large datasets, as the company annually risk-assesses $9T in payments across 120B events worldwide that span the entire financial risk lifecycle: from onboarding and digital activity to card payments and real-time
More news about: Feedzai
Mar 24, 2026, 06:00 ET Feedzai Unveils RiskFM AI Foundation Model for Financial Crime Prevention
actively adapt to evade detection in real-time."Feedzai is uniquely positioned to explore large datasets, as the company annually risk-assesses $9T in payments across 120B events worldwide that span the entire financial risk lifecycle: from onboarding and digital activity to card payments and real-time
More news about: Feedzai